• Welcome Guest user
  • Log in | Register
 
Athens log in
Username Password  
Forgot your password?
Subscribe now to view full content , or if you already have an account,
please Login to access this feature
Subscribe now to view full content, or if you already have an account,
please Login to access this feature
Subscribe now to access this feature, or if you already have an account,
please Login.
 
 
  • Advanced search
Cambridge University Press logo
Stahl's Essential Psychopharmacology Online
In Collaboration With NEI
Stahl's Essential Psychopharmacology

Navigation

  • Home
  • Essential Psychopharmacology
  • Prescriber's Guide
  • Stahl's Illustrated
  • DrugInteraction
  • Teachers Set
 
  • My Bookmarks
  • TOC
  • Perphenazine
  • Duloxetine
  • Citalopram
  • Methylphenidate (D,L)
  • Perospirone
  • Fluphenazine
  • Guanfacine
  • Therapeutics
  • Side Effects
  • Dosing and Use
  • Special Populations
  • Art of Psychopharmacology
  • Suggested Reading

Guanfacine

THERAPEUTICS

Brands

  • Intuniv (pending approval)
  • Tenex
  • see index for additional brand names

Generic?

  • Yes (not for guanfacine ER)

Class

  • Centrally acting alpha 2A agonist; antihypertensive

Commonly Prescribed For

  • (bold for FDA approved)
  • Hypertension
  • Attention deficit hyperactivity disorder (ADHD) in children ages 6­17 (Intuniv, pending approval)
  • Oppositional defiant disorder
  • Pervasive developmental disorders
  • Motor tics
  • Tourette's syndrome

How The Drug Works

  • For hypertension, stimulates alpha 2A adrenergic receptors in the brain stem, reducing sympathetic outflow from the CNS and decreasing peripheral resistance, renal vascular resistance, heart rate, and blood pressure
  • For ADHD, theoretically has central actions on postsynaptic alpha 2A receptors in the prefrontal cortex

How Long Until It Works

  • For ADHD, can take a few weeks to see maximum therapeutic benefits
  • Blood pressure may be lowered 30­60 minutes after first dose; greatest reduction seen after 2­4 hours
  • May take several weeks to control blood pressure adequately

If It Works

  • The goal of treatment of ADHD is reduction of symptoms of inattentiveness, motor hyperactivity, and/or impulsiveness that disrupt social, school, and/or occupational functioning
  • Continue treatment until all symptoms are under control or improvement is stable and then continue treatment indefinitely as long as improvement persists
  • Reevaluate the need for treatment periodically
  • Treatment for ADHD begun in childhood may need to be continued into adolescence and adulthood if continued benefit is documented

If It Doesn’t Work

  • Consider adjusting dose or switching to another agent
  • Consider behavioral therapy
  • Consider the presence of noncompliance and counsel patient and parents
  • Consider evaluation for another diagnosis or for a comorbid condition (e.g., bipolar disorder, substance abuse, medical illness, etc.)

Best Augmenting Combos for Partial Response or Treatment-Resistance

  • Best to attempt another monotherapy prior to augmenting for ADHD
  • Possibly combination with stimulants (with caution as benefits of combination poorly documented)
  • Combinations for ADHD should be for the expert, while monitoring the patient closely, and when other treatment options have failed
  • Chlorthalidone, thyazide-type diuretics, and furosemide for hypertension

Tests

  • Blood pressure should be checked regularly during treatment
 

Current Prices for Individual Subscribers (prices are subject to change)

  Pay-per-view Subscription (48 hours) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447990


$ 40
  Annual Subscription (Single User) Unit price

Subscribe

Stahl's Essential Psychopharmacology Online

Revised and Updated Edition 3rd Edition

ISBN: 9780511447983


$ 195
  Print + Online Access (One Year, Single User) Unit price

Purchase

Stahl's Essential Psychopharmacology Online

Digital Edition: Print and Online

Once you are sent the Digital Edition, just enter the code from the inside back cover to activate your one-year access to www.stahlonline.org.

ISBN: 9780521746090


$225
For pricing and information for Academic and Medical Libraries, Corporate, Nonprofit or Government Institutions and/or special sales or website sponsorship,

for the Americas please contact:
Cambridge Library Sales,
stahlonline@cambridge.org,
800-221-4512, x6535.

For the rest of the world, please contact:
academicsales@cambridge.org
or call +44 (0) 1223 325741.

Australia and New Zealand
Phone: +61 (3) 8671 1400,
Fax: +61 3 9676 9966,
Email: enquiries@cambridge.edu.au.

 

Footer links

  • About Cambridge University Press
  • About NEI
  • About Dr. Stahl
  • About the Illustrator
  • © Cambridge University Press 2008.
  • Copyright statement
  • Privacy Policy
  • Accessibility
  • Terms of use
  • FAQ
  • Help
  • View Access Details
  • Contact us